Studies have shown that RUVBL1/2 interferes with the RNA binding activity of YTHDF1, reducing the translation of cancer-related genes and inhibiting tumor cell proliferation and invasion, demonstrating significant antitumor effects in CRC (179). This evidence concerns the gene YTHDF1 and cancer.